VINCRISTINE SULFATE PFS Drug Patent Profile
✉ Email this page to a colleague
When do Vincristine Sulfate Pfs patents expire, and what generic alternatives are available?
Vincristine Sulfate Pfs is a drug marketed by Hospira and Teva Pharms Usa and is included in two NDAs.
The generic ingredient in VINCRISTINE SULFATE PFS is vincristine sulfate. There are thirteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the vincristine sulfate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for VINCRISTINE SULFATE PFS?
- What are the global sales for VINCRISTINE SULFATE PFS?
- What is Average Wholesale Price for VINCRISTINE SULFATE PFS?
Summary for VINCRISTINE SULFATE PFS
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 48 |
| Clinical Trials: | 478 |
| Patent Applications: | 1,626 |
| DailyMed Link: | VINCRISTINE SULFATE PFS at DailyMed |
Recent Clinical Trials for VINCRISTINE SULFATE PFS
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Medical College of Wisconsin | Phase 1 |
| AbbVie | Phase 1 |
| Andrew E. Place | Phase 1 |
Pharmacology for VINCRISTINE SULFATE PFS
| Drug Class | Vinca Alkaloid |
US Patents and Regulatory Information for VINCRISTINE SULFATE PFS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira | VINCRISTINE SULFATE PFS | vincristine sulfate | INJECTABLE;INJECTION | 071484-001 | Apr 19, 1988 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Teva Pharms Usa | VINCRISTINE SULFATE PFS | vincristine sulfate | INJECTABLE;INJECTION | 075493-001 | Sep 1, 1999 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
